12 May 2015
Capita to become strategic partner to Central London Community Healthcare NHS
Trust
Capita plc (`Capita') announced today that it has been selected as preferred
bidder to form a strategic partnership to deliver corporate services for
Central London Community Healthcare NHS Trust (CLCH). The contract is expected
to be worth £80m over ten years to Capita whilst delivering significant budget
savings to CLCH.
CLCH is the largest community healthcare services provider in London, with over
3,000 staff supporting a population of more than 1 million people across
Barnet, Hammersmith & Fulham, Kensington & Chelsea and Westminster and beyond.
CLCH is one of only two NHS Trusts in London, and one of only 18 across
England, which exclusively delivers out-of-hospital, community-based NHS
healthcare services.
Capita will manage and deliver a range of core support services on behalf of
the Trust, including ICT, HR (payroll and recruitment), estates and facilities
management followed by the planned delivery of finance services. The
partnership will enable CLCH staff to benefit from innovation in technology and
process and operational management, helping to improve the quality of the
corporate services for all CLCH staff at a lower cost.
Capita will also bring additional business development and change capability to
help support the Trust's service transformation and growth plans.
Andy Parker, Chief Executive, Capita, said: "This contract is testament to
Capita's experience in supporting the health sector and wider public sector and
highlights the depth and breadth of our services and expertise as a strategic
partner. Capita has more than 25 years' experience of working with the NHS and
healthcare organisations, including 95% of NHS trusts, and we have shown our
commitment to enhancing efficiency and transforming services that support
professionals to deliver for their patients.
"The NHS continues to face significant challenges in delivering services more
effectively and more efficiently, while still improving patient care. This
partnership will help support these ambitions by providing insight driven
simplified, streamlined and cost effective corporate services to CLCH."
James Reilly, Chief Executive of CLCH added: "The strategic partnership will
help us to protect investment in frontline services; delivering effective and
efficient corporate services that allow our clinical teams to focus on
providing the best possible patient care. The partnership will also help us
grow as an organisation; developing new services and improving existing ones to
better meet the need of both patients and commissioners. It will be a key part
of helping us deliver the savings needed in 2015/16 and beyond."
-Ends-
For further information:
Capita plc
Tel: 020 7654 2219
Shona Nichols, Corporate Communications Director
Andrew Ripper, Head of Investor Relations
Media enquiries only:
Capita press office
Annabelle Chalker/Kirsty Sewter
Tel: 020 7654 2399
Email: Annabelle.Chalker@capita.co.uk/Kirsty.Sewter@capita.co.uk
Twitter: @CapitaPress
Notes to editors
Capita plc is the UK's leading provider of customer management, administration
and integrated professional support service solutions, helping public and
private sector organisations to thrive. With 68,000 people at over 400 main
sites, primarily in the UK, Capita uses its expertise, infrastructure and scale
benefits to transform its clients' services, driving down costs and adding
value. All of our solutions are shaped by industry insight and a strong people
and values focused approach to designing services. Around 70 per cent of our
people have transferred to Capita with contracts and acquisitions and we have
extensive experience of delivering large, complex public services. Some 3,000
employees currently support our significant activities across the healthcare
sector, providing a range of professional support services to help NHS and
healthcare organisations deliver safe and effective healthcare for the public.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.